• 제목/요약/키워드: health costs

검색결과 1,021건 처리시간 0.023초

조산원과 병원 분만 산모의 재원일 수, 의료비용, 산후불편감과 의료서비스 만족도 비교 (Length of Stay, Health Care Cost, Postpartum Discomfort, and Satisfaction with Medical Service in Puerperas Giving Birth in Midwifery Clinic and Hospitals)

  • 박미란;이주영
    • 여성건강간호학회지
    • /
    • 제24권1호
    • /
    • pp.24-32
    • /
    • 2018
  • Purpose: To determine traits related to pregnancy and delivery, length of stay, health care cost, postpartum discomfort, and satisfaction with medical service of puerperas giving birth in midwifery clinic and hospitals. Methods: This study used a comparative survey design. Data were collected from a total of 140 postpartum mothers composed of 70 mothers who gave births in two hospitals and another 70 mothers who delivered in one midwifery clinic. Results: Delivery in midwifery clinic had higher Apgar score at 1 minute and 5 minutes after birth than hospital. Those who delivered in midwifery clinic had shorter stay in the clinic, fewer health care cost, less postpartum discomfort in physical, environmental, social, and cultural areas, higher satisfaction with medical services than those who delivered in hospitals. Conclusion: Results of this study can be used as a basis for studies on giving birth in midwifery clinic and hospitals. They might increase the autonomy of women in giving birth with positive effect on the delivery experience of the mother and her spouse.

장애등급 분포를 활용한 흡연에 의한 뇌졸중 질병부담비용 측정 (Smoking Attributed Economic Burden of Stroke Using Disability Grades)

  • 서유신;안정훈
    • 보건의료기술평가
    • /
    • 제6권2호
    • /
    • pp.106-113
    • /
    • 2018
  • Objectives: The purpose of the study was to estimate the economic burden of stroke in Korea using post stroke disability grades and to measure smoking attributed economic burden. Methods: The disability grade of stroke patient was assessed for stroke patients who did not have a history of stroke before from a large cohort study in Korea. Treatment costs of patients were estimated by the National Health Insurance Service annual statistical report and care cost was estimated by the need of care defined by the assessed disability grades of patients. The population attributable fraction from WHO was used to calculate the proportion of cost due to smoking. Results: The study revealed that the cost of the stroke in 2015 was about 3.228 trillion won, while the care-giver cost was approximately 176 billion won. The cost of the smoking attributed stroke was about 724 billion won. Conclusion: This study is useful for estimating the cost of smoking considering the post-stroke disability and the results is important for achieving the national goal of extending healthy life from the Fourth National Health Promotion Plan.

IoT-Based Health Big-Data Process Technologies: A Survey

  • Yoo, Hyun;Park, Roy C.;Chung, Kyungyong
    • KSII Transactions on Internet and Information Systems (TIIS)
    • /
    • 제15권3호
    • /
    • pp.974-992
    • /
    • 2021
  • Recently, the healthcare field has undergone rapid changes owing to the accumulation of health big data and the development of machine learning. Data mining research in the field of healthcare has different characteristics from those of other data analyses, such as the structural complexity of the medical data, requirement for medical expertise, and security of personal medical information. Various methods have been implemented to address these issues, including the machine learning model and cloud platform. However, the machine learning model presents the problem of opaque result interpretation, and the cloud platform requires more in-depth research on security and efficiency. To address these issues, this paper presents a recent technology for Internet-of-Things-based (IoT-based) health big data processing. We present a cloud-based IoT health platform and health big data processing technology that reduces the medical data management costs and enhances safety. We also present a data mining technology for health-risk prediction, which is the core of healthcare. Finally, we propose a study using explainable artificial intelligence that enhances the reliability and transparency of the decision-making system, which is called the black box model owing to its lack of transparency.

노인의 주관적인 구강건강상태에 따른 구강관리 요구도에 관한 질적연구 (A qualitative research on the needs for oral care according to the subjective oral health status of the elderly)

  • 문상은;홍선화;이보람
    • 한국치위생학회지
    • /
    • 제23권4호
    • /
    • pp.311-321
    • /
    • 2023
  • Objectives: The purpose of this study was conducted an in-depth analysis of the subjective oral status and oral care needs according and problems of the elderly. Methods: A phenomenological research method was from April 13 to 30, 2023, 15 elderly people aged 65 or older in Gwangju and Jeolla regions were surveyed. Results: He was experiencing oral changes such as difficulty chewing, dry mouth and indigestion, sensitive teeth, smell of fear and feeling sensitive when eating sweet or cold food. They were burdened by the financial difficulties of dental treatment costs, the inconvenience caused by frequent visits, and the pain experienced during treatment. Realized the need for necessity of oral care education, and their confidence was restored through dental treatment. It was necessary the image recovery of dentistry, and they wanted to maintain oral health through the expansion of treatment health insurance. Conclusions: Consequently, it is necessary to develop a practical oral health management program for the elderly based on social communication regarding of the elderly and to expand health insurance coverage.

산업보건 및 환경분야에 대한 활동기준원가계산 및 관리의 응용 (Activity-Based Costing and Management Applied to Occupational and Environmental Health)

  • 박두용;마이클 티 브랜트;스티븐 피 르빈;백남원
    • 한국산업보건학회지
    • /
    • 제6권1호
    • /
    • pp.144-155
    • /
    • 1996
  • During the 1990s the workplace has grown more complex and business competition has increased world-wide. All organizations, whether for-profit or non-profit have been forced to respond to market changes. More advanced information and technology, greater product diversity, shorter product life cycles, increased quality requirements, more regulation oversight, decreasing productivity, more competitors, and increasing overhead costs have motivated organizations to focus on ways to deliver products cheaper, better, and faster. Many organizations are searching for ways to reduce costs through downsizing, reengineering business processes, implementing quality management, outsourcing, and improving cost management. Support departments that provide services internal to an organization such as human resources, legal, and environmental, safety, and health (ES&H) are often the first organization targeted for cost reduction and cost control initiatives because these functions are part of a rapidly increasing overhead cost. Recently, ES&H functions are incresingly being integrated into the business of business to contribute value to organization beyond mere compliance with ES&H regulations. The discussions and development of the ISO compatible Environmental Management Standards or Occupational Safety and Health Management Standards is another impetus to integrate ES&H function into the business of business. Thus, ES&H professional need new skills to analyze the cost of their function and communicate the value of the products and services they provide. In recent years, the need for and the importance developing cost management and business skills by ES&H professionals have been emphasized in the literature. Communicating with decision makers in terms of cost and value to the organization, and by using business language and business arguments is the first step toward effectively integrating ES&H activities into the business of business. Activity-based costing (ABC) is a cost management method that measures the cost of a product or service based on the actual use of resources by activities, and based on the actual amount of activities used to produce a product or service. ABC is recommended as a tool for managers of ES&H organizations to determine the cost of developing and providing ES&H products within a for-profit firm or non-profit agency. This paper discusses the trend of integration of ES&H functions into the mainstream of business activities within an organization. The general principles of treditional cost accounting are presented as a bases for understandging why and how ABC will provide more accurate estimates of cost. The principles and concepts of ABS are presented as a tool for determining more accurately the true cost of ES&H products and services.

  • PDF

CAD-CAM을 이용한 RPD 지대치의 retrofit crown 제작 증례 (Fabricating retrofit crowns to an existing removable partial denture by CAD-CAM: a case report)

  • 이혁순;김성아;방주혁;김성용;장희원;이근우;이용상
    • 대한치과보철학회지
    • /
    • 제62권2호
    • /
    • pp.140-145
    • /
    • 2024
  • 가철성 국소의치를 사용하는 환자의 잔존 치아가 우식, 마모, 부식, 파절 등의 이유로 보철 수복이 필요한 경우가 있다. 가철성 국소의치의 구조물과 접촉하는 부분이 많은 지대치의 보철 수복이 필요한 경우, 서베이드 크라운을 제작 후 가철성 국소의치를 새로 제작하는 것이 통상적인 방법이다. 이럴 경우, 환자가 적응하기까지 오랜 시간이 걸리고, 시간적, 경제적 비용이 발생한다. 한편, 손상된 치아 외에 구강 내 다른 부분에서 가철성 국소의치의 지지, 유지 및 안정을 일부분 제공하는 경우 기존 국소의치의 사용은 임상적으로 양호하다. 이 때 기존 국소의치를 유지하면서 해당 치아를 보철 수복한다면, 환자는 불편과 비용을 줄이면서 기존 가철성 국소의치를 사용할 수 있다. 이처럼 국소의치에 맞추어 보철을 제작하는 retrofit crown 제작과정에서 Computer Aided Design-Computer Aided Manufacturing(CAD-CAM)의 발전과 지르코니아의 물리적 성질이 개선되면서 디지털 방식이 적용되고 있다. 본 증례는 하악에서 가철성 국소의치를 사용하는 환자의 지대치가 심하게 마모되어 국소의치에 맞추어 지르코니아 크라운을 제작한 케이스로, 환자와 술자 모두 만족하는 결과를 얻었기에 본 증례를 보고하는 바이다.

한국 건강보험법 시행 30년의 역사와 과제 (Overview and Insight After 30 years of implementing the National Health Insurance Regulations in Korea)

  • 신언항
    • 의료법학
    • /
    • 제8권2호
    • /
    • pp.9-35
    • /
    • 2007
  • The Health care program in Korea has now been systemized after 30 years of declaring the inauguration of the national health insurance system by the current government. The national health care covering all Korean citizens was achieved after 12 years of implementing the national health insurance and the health care program since 1977. Hundreds of multiple operational agencies managing the insured individually had undergone the amalgamation process from 1998 to 2000, and had been restructured as one agency, the National Health Insurance Corporation. In 2003, the community/area based financial management was also merged together with the employment based financial management. The National health care system of Korea offer various merits, compared with that of other countries, such as health care provision covering all Koreans, low insurance premium, accessibility of medical services/facilities etc. However, there are still some weak features which need to be addressed for improvement; below expectation insurance cover system, mistrust on the medical services, low medical charges resulted from excessive restrictions, and unstable financial status of the national health insurance etc. Therefore, the National health care system should continue to evolve to re-establish itself as more effective national health care system by further strengthening its merits, and by improving its weaknesses; with adopting the positive system to optimize the costs of prescribed medicines/drugs, applying simpler insurance coverage system to calculate the optimum medical charges, promoting private medical insurances, and increasing insurance premium etc.

  • PDF

Cost Effectiveness Analysis of Different Management Strategies between Best Supportive Care and Second-line Chemotherapy for Platinum-resistant or Refractory Ovarian Cancer

  • Luealon, Phanida;Khempech, Nipon;Vasuratna, Apichai;Hanvoravongchai, Piya;Havanond, Piyalamporn
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권2호
    • /
    • pp.799-805
    • /
    • 2016
  • Background: There is no standard treatment for patients with platinum-resistant or refractory epithelial ovarian cancer. Single agent chemotherapies have evidence of more efficacy and less toxicity than combination therapy. Most are very expensive, with appreciable toxicity and minimal survival. Since it is difficult to make comparison between outcomes, economic analysis of single-agent chemotherapy regimens and best supportive care may help to make decisions about an appropriate management for the affected patients. Objective: To evaluate the cost effectiveness of second-line chemotherapy compared with best supportive care for patients with platinum-resistant or refractory epithelial ovarian cancer. Materials and Methods: A Markov model was used to estimate the effectiveness and total costs associated with treatments. The hypothetical patient population comprised women aged 55 with platinum-resistant or refractory epithelial ovarian cancer. Four types of alternative treatment options were evaluated: 1) gemcitabine followed by BSC; 2) pegylated liposomal doxorubicin (PLD) followed by BSC; 3) gemcitabine followed by topotecan; and 4) PLD followed by topotecan. Baseline comparator of alternative treatments was BSC. Time horizon of the analysis was 2 years. Health care provider perspective and 3% discount rate were used to determine the costs of medical treatment in this study. Quality-adjusted life-years (QALY) were used to measure the treatment effectiveness. Treatment effectiveness data were derived from the literature. Costs were calculated from unit cost treatment of epithelial ovarian cancer patients at various stages of disease in King Chulalongkorn Memorial Hospital (KCMH) in the year 2011. Parameter uncertainty was tested in probabilistic sensitivity analysis by using Monte Carlo simulation. One-way sensitivity analysis was used to explore each variable's impact on the uncertainty of the results. Results: Approximated life expectancy of best supportive care was 0.182 years and its total cost was 26,862 Baht. All four alternative treatments increased life expectancy. Life expectancy of gemcitabine followed by BSC, PLD followed by BSC, gemcitabine followed by topotecan and PLD followed by topotecan was 0.510, 0.513, 0.566, and 0.570 years, respectively. The total cost of gemcitabine followed by BSC, PLD followed by BSC, gemcitabine followed by topotecan and PLD followed by topotecan was 113,000, 124,302, 139,788 and 151,135 Baht, respectively. PLD followed by topotecan had the highest expected quality-adjusted life-years but was the most expensive of all the above strategies. The incremental cost-effectiveness ratios (ICER) of gemcitabine followed by BSC, PLD followed by BSC, gemcitabine followed by topotecan and PLD followed by topotecan was 344,643, 385,322, 385,856, and 420,299 Baht, respectively. Conclusions: All of the second-line chemotherapy strategies showed certain benefits due to an increased life-year gained compared with best supportive care. Moreover, gemcitabine as second-line chemotherapy followed by best supportive care in progressive disease case was likely to be more effective strategy with less cost from health care provider perspective. Gemcitabine was the most cost-effective treatment among all four alternative treatments. ICER is only an economic factor. Treatment decisions should be based on the patient benefit.

크레메진의 투석도입 지연효과에 따른 진행성 신부전증환자의 비용감소분 추계 (Estimating the Cost Savings Due to the Effect of Kremezin in Delaying the Initiation of Dialysis Treatments among Patients with Chronic Renal Failure)

  • 조우현;이선미;김형종;이호영;우태욱;강혜영
    • Journal of Preventive Medicine and Public Health
    • /
    • 제39권2호
    • /
    • pp.149-158
    • /
    • 2006
  • Objectives : We wanted to evaluate the economic value of a pharmaceutical product, Kremezin, for treating patients with chronic renal failure (CRF) by estimating the amount of cost savings due to its effect for delaying the initiation of dialysis treatments. Methods : We defined a conventional treatment for CRF accompanied by Kremezin therapy as 'the treatment group' and only conventional treatment as 'the alternative group.' The types of costs included were direct medical and nonmedical costs and costs of productivity loss. The information on the effect of Kremezin was obtained from the results of earlier clinical studies. Cost information was derived from the administrative data for 20 hemodialysis and 20 peritoneal dialysis patients from one tertiary care hospital, and also from the administrative data of 10 hemodialysis patients from one free-standing dialysis center. Per-capita cost savings resulting from Kremezin therapy were separately estimated for the cases with delay for the onset of hemodialysis and the cases with immediate performance of peritoneal dialysis. By computing the weighted average for the cases of hemodialysis and peritoneal dialysis, the expected per-capita cost savings of a patient with CRF was obtained. Using a discount rate of 5%, future cost savings were converted to the present value. Results : The present value of cumulative cost savings per patient with CRF from the societal perspective would be $18,555,000{\sim}29,410,000$ Won or $72,104,000{\sim}112,523,000$ Won if Kremezin delays the initiation of dialysis by 1 or 4 years. Conclusions : The estimated amount of cost savings resulting from treating CRF patients with Kremezin confirms that its effect for delaying the onset of dialysis treatments has a considerable economic value.

위암 수술 환자의 건강결과 측정을 위한 동반상병 측정도구의 유용성 연구 (Usefulness of Comorbidity Indices in Operative Gastric Cancer Cases)

  • 황세민;윤석준;안형식;안형진;김상후;경민호;이은경
    • Journal of Preventive Medicine and Public Health
    • /
    • 제42권1호
    • /
    • pp.49-58
    • /
    • 2009
  • Objectives : The purpose of the current study was to evaluate the usefulness of the following four comorbidity indices in gastric cancer patients who underwent surgery: Charlson Comorbidity Index(CCI), Cumulative Illness rating scale(CIRS), Index of Co-existent Disease(ICED), and Kaplan-Feinstein Scale(KFS). Methods : The study subjects were 614 adults who underwent surgery for gastric cancer at K hospital between 2005 and 2007. We examined the test-retest and inter-rater reliability of 4 comorbidity indices for 50 patients. Reliability was evaluated with Spearman rho coefficients for CCI and CIRS, while Kappa values were used for the ICED and KFS indices. Logistic regression was used to determine how these comorbidity indices affected unplanned readmission and death. Multiple regression was used for determining if the comorbidity indices affected length of stay and hospital costs. Results : The test-retest reliability of CCI and CIRS was substantial(Spearman rho=0.746 and 0.775, respectively), while for ICED and KFS was moderate(Kappa=0.476 and 0.504, respectively). The inter-rater reliability of the CCI, CIRS, and ICED was moderate(Spearman rho=0.580 and 0.668, and Kappa=0.433, respectively), but for KFS was fair(Kappa=0.383). According to the results from logistic regression, unplanned readmissions and deaths were not significantly different between the comorbidity index scores. But, according to the results from multiple linear regression, the CIRS group showed a significantly increased length of hospital stay(p<0.01). Additionally, CCI showed a significant association with increased hospital costs (p<0.01). Conclusions : This study suggests that the CCI index may be useful in the estimation of comorbidities associated with hospital costs, while the CIRS index may be useful where estimatation of comorbiditie associated with the length of hospital stay are concerned.